XML 29 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Stockholders' Equity - USD ($)
Paloma [Member]
Common Stock [Member]
Paloma [Member]
Additional Paid-in Capital [Member]
Paloma [Member]
Vasculo Medics [Member]
Common Stock [Member]
Vasculo Medics [Member]
Additional Paid-in Capital [Member]
Vasculo Medics [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2013             5,813,785      
Balance at Dec. 31, 2013             $ 5,814 $ 67,390,493 $ (60,937,550) $ 6,458,757
Stock Issued During Period, Shares, New Issues             8,895,685      
Issuance of common stock, net of offering costs             $ 8,896 31,841,071   31,849,967
Employee and director stock-based compensation               1,606,947   1,606,947
Warrants issued to consultants               547,061   547,061
Stock Issued During Period, Shares, Acquisitions 2,500,000     220,000            
Common stock issued for acquisitions $ 2,500 $ 6,247,500 $ 6,250,000 $ 220 $ 549,780 $ 550,000        
Issuance of common stock to third party for assumption of liabilities (in shares)             150,000      
Issuance of common stock to third party for assumption of liabilities             $ 150 272,952   273,102
Retirement of common stock originally issued to a third party for assumption of liabilities (in shares)             (99,332)      
Retirement of common stock originally issued to a third party for assumption of liabilities             $ (99)     (99)
Issuance of common stock as settlement of accounts payable and accrued liabilities (in shares)             160,056      
Issuance of common stock as settlement of accounts payable and accrued liabilities             $ 160 587,441   $ 587,601
Stock Issued During Period, Shares, Issued to Law Firm in Connection with Conversion of Outstanding Debt             53,457     53,457
Common stock issued as settlement of an outstanding liability to law firm             $ 53 214,112   $ 214,165
Common stock issued as payment of notes payable (in shares)             274,764      
Common stock issued as payment of notes payable             $ 275 979,796   980,071
Common stock issued as payment of notes payable - related party (in shares)             646,553      
Common stock issued as payment of notes payable - related party             $ 646 3,200,231   3,200,877
Net Income (Loss) Available to Common Stockholders, Basic                 (14,352,824) (14,352,824)
Balance (in shares) at Dec. 31, 2014             18,614,968      
Balance at Dec. 31, 2014             $ 18,615 113,437,384 (75,290,374) 38,165,625
Employee and director stock-based compensation               2,095,086   2,095,086
Net Income (Loss) Available to Common Stockholders, Basic                 (23,820,675) (23,820,675)
Balance (in shares) at Dec. 31, 2015             18,614,968      
Balance at Dec. 31, 2015             $ 18,615 115,531,954 $ (99,111,049) 16,439,520
Adjustments to Additional Paid in Capital, Change in Fair Value of Warrants Issued               $ (516)   $ (516)